Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy (Q41592367)

From Wikidata

Jump to navigation Jump to search

scientific article published on August 1997

Language	Label	Description	Also known as
English	Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy	scientific article published on August 1997

Statements

scholarly article

1 reference

Europe PubMed Central

4 October 2017

1 reference

Europe PubMed Central

Effects of angiotensin-converting enzyme inhibition and angiotensin II AT1 receptor antagonism on cardiac parameters in left ventricular hypertrophy (English)

1 reference

Europe PubMed Central

4 October 2017

5

object named as

T Unger

1 reference

Europe PubMed Central

4 October 2017

author name string

Y C Zhu

1

1 reference

Europe PubMed Central

4 October 2017

Y Z Zhu

2

1 reference

Europe PubMed Central

4 October 2017

P Gohlke

3

1 reference

Europe PubMed Central

4 October 2017

H M Stauss

4

1 reference

Europe PubMed Central

4 October 2017

language of work or name

0 references

publication date

1 August 1997

1 reference

Europe PubMed Central

4 October 2017

American Journal of Cardiology

1 reference

Europe PubMed Central

4 October 2017

80

1 reference

Europe PubMed Central

4 October 2017

3A

1 reference

Europe PubMed Central

4 October 2017

110A-117A

1 reference

Europe PubMed Central

4 October 2017

Cardiomyopathy of overload. A major determinant of prognosis in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

The effects of long-term pressure-overload and aging on the myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effect on the myocardial energy metabolism of angiotensin-converting enzyme inhibition in chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Energetic changes of myocardium as an adaptation to chronic hemodynamic overload and thyroid gland activity.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Two putative active centers in human angiotensin I-converting enzyme revealed by molecular cloning

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

A dipeptidyl carboxypeptidase that converts angiotensin I and inactivates bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Tissue-specific activation of cardiac angiotensin converting enzyme in experimental heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Cellular distribution of angiotensin-converting enzyme after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

The angiotensin AT2 receptor stimulates protein tyrosine phosphatase activity and mediates inhibition of particulate guanylate cyclase

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Protein tyrosine phosphatase inhibition by angiotensin II in rat pheochromocytoma cells through type 2 receptor, AT2.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

The angiotensin AT2-receptor mediates inhibition of cell proliferation in coronary endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Inhibition of angiotensin converting enzyme: mechanism and substrate dependence

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Distribution and metabolism of angiotensin I and II in the blood vessel wall

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Converting enzyme inhibitors in cardiovascular therapy: current status and future potential

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effect of low-dose treatment with perindopril on cardiac function in stroke-prone spontaneously hypertensive rats: role of bradykinin

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

HOE 140, a new highly potent and long-acting bradykinin antagonist in conscious rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Hoe 140 a new potent and long acting bradykinin-antagonist: in vitro studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Hoe 140 a new potent and long acting bradykinin-antagonist: in vivo studies

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Angiotensin II receptor antagonists and the kidney.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effects of losartan on angiotensin and bradykinin peptides and angiotensin-converting enzyme

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Influence of chronic captopril therapy on the infarcted left ventricle of the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effect of enalapril on survival in patients with reduced left ventricular ejection fractions and congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Limitation of experimental infarct size by an angiotensin-converting enzyme inhibitor

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Reduction of myocardial infarct size by ramiprilat is independent of angiotensin II synthesis inhibition

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Reduction of infarct size by local angiotensin-converting enzyme inhibition is abolished by a bradykinin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Collagen remodeling of the pressure-overloaded, hypertrophied nonhuman primate myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Patterns of myocardial fibrosis

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Remodeling of the rat right and left ventricles in experimental hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Regulation of fibrillar collagen types I and III and basement membrane type IV collagen gene expression in pressure overloaded rat myocardium

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Remodelling of the heart in DOCA-salt hypertensive rats by propranolol and by an alpha-2 agonist, rilmenidine

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effects of angiotensin II and angiotensin II antagonist saralasin on cell growth and renin in 3T3 and SV3T3 cells

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Anti-aldosterone treatment and the prevention of myocardial fibrosis in primary and secondary hyperaldosteronism

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Angiotensin II and left ventricular growth in newborn pig heart

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Long-term angiotensin II antagonism in spontaneously hypertensive rats: effects on blood pressure and cardiovascular amplifiers

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Cardiac and vascular effects of long-term losartan treatment in stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Converting enzyme inhibition specifically prevents the development and induces regression of cardiac hypertrophy in rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

A specific B2-bradykinin receptor antagonist HOE 140 abolishes the antihypertrophic effect of ramipril

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Exercise-induced myocardial capillary growth in the spontaneously hypertensive rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effect of early onset angiotensin converting enzyme inhibition on myocardial capillaries

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Capillary neoformation in the rat heart--stereological studies on papillary muscles in hypertrophy and physiologic growth

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Blockade of bradykinin B2 receptors prevents the increase in capillary density induced by chronic angiotensin-converting enzyme inhibitor treatment in stroke-prone spontaneously hypertensive rats

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

The angiotensin AT2 receptor: searching for signal-transduction pathways and physiological function.

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Signals for the remodeling of the cardiac interstitium in systemic hypertension

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

Effects of the angiotensin converting enzyme inhibitor, ramipril, in isolated ischaemic rat heart are abolished by a bradykinin antagonist

1 reference

https://api.crossref.org/works/10.1016%2FS0002-9149%2897%2900465-7

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/S0002-9149(97)00465-7

1 reference

Europe PubMed Central

4 October 2017

1 reference

Europe PubMed Central

4 October 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q41592367&oldid=1924808406"